Compare CRVS & CRTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRVS | CRTO |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 843.7M | 751.6M |
| IPO Year | 2016 | 2013 |
| Metric | CRVS | CRTO |
|---|---|---|
| Price | $10.60 | $15.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $31.50 | $20.05 |
| AVG Volume (30 Days) | ★ 998.8K | 309.3K |
| Earning Date | 11-05-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.04 | 38.95 |
| EPS | N/A | ★ 0.49 |
| Revenue | N/A | ★ $2,296,692,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.85 |
| P/E Ratio | ★ N/A | $31.92 |
| Revenue Growth | N/A | ★ 27.65 |
| 52 Week Low | $6.39 | $13.95 |
| 52 Week High | $26.95 | $25.29 |
| Indicator | CRVS | CRTO |
|---|---|---|
| Relative Strength Index (RSI) | 50.34 | 51.27 |
| Support Level | $9.21 | $14.12 |
| Resistance Level | $10.81 | $15.85 |
| Average True Range (ATR) | 0.64 | 0.62 |
| MACD | 0.12 | 0.16 |
| Stochastic Oscillator | 73.19 | 73.74 |
Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.
Criteo SA is an ad-tech company in the digital advertising market. Its technology allows retailer advertisers to launch multichannel and cross-device marketing campaigns in real time. With real-time return on investment analysis of the ads, the firm's clients can adjust their marketing strategies dynamically. It has two reportable segments: Retail Media and Performance Media. Retail Media: This segment encompasses revenue generated from brands, agencies, and retailers for the purchase and sale of retail media digital advertising inventory and audiences, and services. Performance Media: This segment encompasses targeting capabilities and supply and AdTech services. The majority of its revenues is generated from the performance media segment.